AIM: To evaluate the association between serum 25-hydroxyvitamin D [25(OH)D] and arterial stiffness in patients with type 2 diabetes. METHODS: Serum 25(OH)D was measured in a cross-sectional sample of 131 men and 174 women aged 30 years and over in Korea. Arterial stiffness was assessed by pulse wave velocity (PWV) obtained with a VP-2000 pulse wave unit. Fasting plasma glucose, insulin, lipid profile, HbA1c, calcium, phosphorous, and HS-CRP were measured. RESULTS: The prevalence of vitamin D deficiency was high (85.9%). Those with lower vitamin D levels had increased PWV. Using multivariate regression analysis, low 25(OH)D concentrations independently predicted PWV (p<0.001) in people with type 2 diabetes after adjustment for other risk factors such as age, smoking, hypertension, HS-CRP, diabetes duration, hypertension duration, HbA1c, and BMI. CONCLUSIONS: Vitamin D deficiency is common in type 2 diabetes, and a low 25(OH)D level is significantly associated with increased arterial stiffness in these patients. Vitamin D may influence the development of cardiovascular disease. Clinical intervention studies are needed to clarify whether treatment with vitamin D decreases the risk of cardiovascular disease in patients with type 2 diabetes.
AIM: To evaluate the association between serum 25-hydroxyvitamin D [25(OH)D] and arterial stiffness in patients with type 2 diabetes. METHODS: Serum 25(OH)D was measured in a cross-sectional sample of 131 men and 174 women aged 30 years and over in Korea. Arterial stiffness was assessed by pulse wave velocity (PWV) obtained with a VP-2000 pulse wave unit. Fasting plasma glucose, insulin, lipid profile, HbA1c, calcium, phosphorous, and HS-CRP were measured. RESULTS: The prevalence of vitamin D deficiency was high (85.9%). Those with lower vitamin D levels had increased PWV. Using multivariate regression analysis, low 25(OH)D concentrations independently predicted PWV (p<0.001) in people with type 2 diabetes after adjustment for other risk factors such as age, smoking, hypertension, HS-CRP, diabetes duration, hypertension duration, HbA1c, and BMI. CONCLUSIONS:Vitamin D deficiency is common in type 2 diabetes, and a low 25(OH)D level is significantly associated with increased arterial stiffness in these patients. Vitamin D may influence the development of cardiovascular disease. Clinical intervention studies are needed to clarify whether treatment with vitamin D decreases the risk of cardiovascular disease in patients with type 2 diabetes.
Authors: D Agnoletti; A S Mansour; Y Zhang; A D Protogerou; S Ouerdane; J Blacher; M E Safar Journal: J Hum Hypertens Date: 2016-09-08 Impact factor: 3.012
Authors: Francesco Giallauria; Yuri Milaneschi; Toshiko Tanaka; Marcello Maggio; Marco Canepa; Palchamy Elango; Carlo Vigorito; Edward G Lakatta; Luigi Ferrucci; James Strait Journal: J Clin Endocrinol Metab Date: 2012-07-05 Impact factor: 5.958
Authors: Diane F Birt; Terri Boylston; Suzanne Hendrich; Jay-Lin Jane; James Hollis; Li Li; John McClelland; Samuel Moore; Gregory J Phillips; Matthew Rowling; Kevin Schalinske; M Paul Scott; Elizabeth M Whitley Journal: Adv Nutr Date: 2013-11-06 Impact factor: 8.701
Authors: Pranati Jha; Lawrence M Dolan; Philip R Khoury; Elaine M Urbina; Thomas R Kimball; Amy S Shah Journal: Diabetes Care Date: 2015-05-26 Impact factor: 19.112